Citadel Advisors
PRVA icon

Citadel Advisors’s Privia Health PRVA Stock Holding History

Citadel Advisors’s Portfolio PRVA Stock Details PRVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$728K Sell
28,300
-10,900
-28% -$252K ﹤0.01% 8979
2026
Q1 		$806K Buy
39,200
+15,400
+65% +$347K ﹤0.01% 8169
2025
Q4 		$564K Buy
23,800
+10,300
+76% +$251K ﹤0.01% 8731
2025
Q3 		$336K Sell
13,500
-42,100
-76% -$906K ﹤0.01% 10104
2025
Q2 		$1.28M Sell
55,600
-86,500
-61% -$2M ﹤0.01% 6567
2025
Q1 		$3.19M Sell
142,100
-29,800
-17% -$692K ﹤0.01% 4654
2024
Q4 		$3.36M Buy
171,900
+75,900
+79% +$1.5M ﹤0.01% 4642
2024
Q3 		$1.75M Sell
96,000
-57,000
-37% -$1.09M ﹤0.01% 5788
2024
Q2 		$2.66M Sell
153,000
-30,400
-17% -$539K ﹤0.01% 4791
2024
Q1 		$3.59M Buy
183,400
+115,300
+169% +$2.44M ﹤0.01% 4498
2023
Q4 		$1.57M Buy
68,100
+15,300
+29% +$342K ﹤0.01% 5811
2023
Q3 		$1.21M Sell
52,800
-8,500
-14% -$216K ﹤0.01% 6175
2023
Q2 		$1.6M Sell
61,300
-10,400
-15% -$275K ﹤0.01% 5569
2023
Q1 		$1.98M Sell
71,700
-4,800
-6% -$127K ﹤0.01% 5392
2022
Q4 		$1.74M Sell
76,500
-4,300
-5% -$120K ﹤0.01% 5742
2022
Q3 		$2.75M Buy
80,800
+69,000
+585% +$2.55M ﹤0.01% 4971
2022
Q2 		$344K Buy
+11,800
New +$300K ﹤0.01% 9502
2022
Q1 		– Sell
-25,600
Closed -$662K – 14368
2021
Q4 		$662K Buy
+25,600
New +$638K ﹤0.01% 8971

Other funds holding PRVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DCP
Durable Capital Partners Bethesda, Maryland $10.3B AUM 29.04% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
RF
Rubicon Founders Nashville, Tennessee $196M AUM 53.12% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VBA
Van Berkom & Associates Montreal, Quebec, Canada $3.1B AUM 12.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

Citadel Advisors's PRVA Position: Q2 2026 in Review

Citadel Advisors reduced its Privia Health (PRVA) stake by 90% in Q2 2026, selling an estimated $10.2M and leaving 48,835 shares worth $1.26M. The position accounts for ﹤0.01% of the portfolio, ranked #7642.

Citadel Advisors first reported a position in PRVA in Q2 2021 and has held it in 19 quarters since. The position peaked at $32.3M in Q3 2022. 301 funds tracked by Wall St. Rank hold PRVA as of Q2 2026.

  • Citadel Advisors held 48,835 shares of Privia Health worth $1.26M as of Q2 2026.
  • Citadel Advisors sold 441,578 Privia Health shares in Q2 2026, an estimated $10.2M.
  • Privia Health made up ﹤0.01% of Citadel Advisors's portfolio in Q2 2026, its #7642 holding.
  • Citadel Advisors first reported a position in Privia Health in Q2 2021 and has held it in 19 quarters since.
  • Citadel Advisors's Privia Health position peaked at $32.3M in Q3 2022.
  • 301 funds tracked by Wall St. Rank held Privia Health as of Q2 2026.

Based on Citadel Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.